Last updated on February 2019

A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

Brief description of study

This study designed to evaluate the long-term efficacy and safety of mirikizumab in participants with moderately to severely active ulcerative colitis (UC).

Clinical Study Identifier: NCT03519945

Contact Investigators or Research Sites near you

Start Over

Raja Affendi Bin Raja Ali

Pusat Perubatan University Kebangsaan Malaysia
Cheras, Kuala Lumpur, Malaysia
  Connect »

Choon Kin Lee

University Malaya Medical Centre
Kuala Lumpur, Malaysia
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.